Inhibitor Therapeutics

INTI · OTC

$0.1099+$0.0119 (+12.14%)TodayMarket closed ·
Prev close $0.098

Who owns INTI

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 55.4% of INTI’s shares.

  • TPB 2012, LLC16.2%
  • Osman (Ronald E)13.7%
  • Black Robe Capital LLC11.5%
  • MOAB Investments LP,6.1%
  • Next 6 largest institutions7.8%
  • All other shareholders44.6%
Top institutional holders of INTI
HolderShares% of shares
TPB 2012, LLC27.92M16.18%
Osman (Ronald E)23.66M13.71%
Black Robe Capital LLC19.90M11.53%
MOAB Investments LP,10.55M6.12%
Virca(Nicholas J)8.73M5.06%
McNulty (James A CPA)1.95M1.13%
Sears (Samuel P Jr)1.23M0.71%
Yanez (Michelle)1.22M0.71%
Vasisht (Niraj)200.00K0.12%
Jerman (Michael Allen)180.41K0.10%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of INTI in the last 6 months.

Latest INTI insider transactions
InsiderTypeSharesValue
Black Robe Capital LLCGift3.20M—
Vasisht NirajAward50.00K—
OSMAN RONALD EAward50.00K—
Yanez MichelleAward50.00K—
SEARS SAMUEL P JRAward50.00K—
ODONNELL FRANCIS E JRAward50.00K—
Jerman Michael AllenAward50.00K—

Short interest

Settled Jul 31, 2026

Shares short
4.64K
Days to cover
1.00
% of shares outstanding
0.00%
Average daily volume
4.96K
Change since last report
+0.0%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.